These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Also for problem cases; successful first line therapy]. MMW Fortschr Med; 2005 Feb 03; 147(5):47. PubMed ID: 15766030 [No Abstract] [Full Text] [Related]
3. [Dihydropyridines are not the only antihypertensives. Calcium blockers in the therapy of elderly hypertensive patients]. Fortschr Med Suppl; 1989 Feb 03; 71():1-18. PubMed ID: 2635677 [No Abstract] [Full Text] [Related]
4. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword. Zanchetti A. Drugs; 1999 Feb 03; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077 [No Abstract] [Full Text] [Related]
5. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension]. Christensen KL. Ugeskr Laeger; 2005 Jan 10; 167(2):153-5. PubMed ID: 15697124 [No Abstract] [Full Text] [Related]
13. Some similarities and differences between verapamil and the dihydropyridines. Antonios TF, MacGregor GA. J Hypertens Suppl; 1998 Jan 17; 16(1):S31-4. PubMed ID: 9534094 [Abstract] [Full Text] [Related]
17. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine? Burnier M, Pruijm M, Wuerzner G. Expert Opin Drug Metab Toxicol; 2009 Aug 17; 5(8):981-7. PubMed ID: 19619074 [Abstract] [Full Text] [Related]